Medtronic

Forecast & Rating30 analysts currently cover Medtronic, with about 60.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $97.84, about 17.6% upside from the current price of $83.21. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 30.3% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Medtronic closely still see room for the stock to rise. Data as of Jul 25, 2026; for reference only and not investment advice.